Showing posts with label biosafety. Show all posts
Showing posts with label biosafety. Show all posts

Thursday, September 8, 2011

Protests against Dangerous Biolab in Boston

WILPF Boston is active in the Stop the Bioterror Lab Coalition anchored by Safety Net Roxbury and composed of several groups and concerned individuals. The Boston University Level 4 Lab would be the 5th or 6th known level 4 lab in the US. These labs are intended to research the most deadly microorganisms known for which there are no cures. Unfortunately, most of the agents listed in the Request for Proposal are known to be of interest for Bioweapons purposes. They are not organisms that are on the public health agenda for Boston or the United States in general. This raises concern of research serving a dangerous purpose in that any supposed defensive research also serves possible offensive applications. For more information on the Bioweapons treaty of 1975, its shortcomings and efforts to strengthen it, see the WILPF UN Reaching Critical Will project page. The BU Biolab is to be housed in a building nearing completion on Albany Street but the lab cannot become operational until it receives a license from the State. Because of community opposition and legal challenges in State and Federal courts, this NIH funded initiative does not have the final go ahead. However, it has received powerful support from both Massachusetts Senators and several representatives. A number of nearby communities including Cambridge, Newton, Arlington, Brookline and Somerville have passed resolutions opposing the placing of this lab in a densely populated urban community because of safety concerns.For more information on the current opposition to the BU Biolab, visit the Stop the Bioterror Lab Coalition web site.


http://boston.wilpf.org/node/20
http://boston.indymedia.org/feature/display/152905

Thursday, June 2, 2011

Deadly E. Coli Strain Kills throughout German_Source Unknown

A highly lethal strain of E. Coli that kills victims by inflicting acute kidney falure has hit Germany.  At least 1500 people have succumbed to serous illness from the biological agent with at least 16 people already dead. 

It is serious.  It is a mystery.

The E. Coli strain has been found to secrete a more potent form of a shiga toxin.  The E. Coli will cling to a person's intestinal wall and release massive amounts of shiga poisons to make people sick, causing amongst other things, sezures and stroke. 

But this new strain of E. Coli also appears to have other behavior that makes it highly unusual, one of which is making it difficult to detect by conventional means. 

E.Coli is a standard microbe used in biological research, both in biomedical and agricultural genetic research. This German strain of E. Coli could have undergone natural or made-made genetic changes to make it more potent.



One of the other main mysteries to this killer strain, is that public health officials cannot trace its source.  They assume it comes from raw vegetables and warn the public from eating raw tomatoes, cucumbers and lettuces.

http://www.nytimes.com/2011/06/02/world/europe/02ecoli.html?_r=1&nl=todaysheadlines&emc=tha2

Wednesday, April 13, 2011

Biological Research Laboratories Can Cause Dangerous and Lethal Human Infections

Researchers must be wary of infections


By Blythe Bernhard / St. Louis Post-Dispatch

The death of a scientist who caught the plague in a laboratory in 2009 shook the disease research community. It was the first such death of a researcher, and 50 years since the last known lab-acquired case of plague.


For the more than 500,000 people who work in laboratories in the United States, occupational health hazards can include infectious diseases spread by live viruses and bacteria.

There’s no state or national tracking system for lab-acquired infections, but one estimate says three of every 1,000 lab workers become infected each year. The most common infections include hepatitis, typhoid fever and tuberculosis, according to the National Institutes of Health.

“We’ve always told people they need to follow safety (precautions) even if what they think they’re working with is benign,” said Susan Cook, a safety officer at Washington University, where scientists work with cultures, including flu, pneumonia, salmonella and E. coli. “You don’t necessarily know what the person next to you is working with all the time.”
......

Basic lab protection includes gloves, coats and eye goggles. Biological safety cabinets keep fumes away from researchers if they need to mix agents.

Still, infections occur when workers breathe in or touch spores.

A student worker at the University of Illinois at Urbana-Champaign somehow contracted cowpox last year in a campus lab that stores the virus. The skin virus presented as an infected cut, according to university officials, and the student recovered.

While all lab workers are offered precautionary vaccines, the student had declined, a university spokeswoman said.

In 2008, a lab worker at a Virginia university contracted vaccinia, the live virus contained in smallpox vaccine. The man in his 20s worked in a cancer research lab with mice that were infected with vaccinia virus. He recovered fully from an infection in his eye and ear.

For complete story:  http://www.bendbulletin.com/article/20110324/NEWS0107/103240320/

Thursday, February 10, 2011

Unsafe Biotech Laboratories in U.S._Biotech Worker Infected with Cow Pox.

 A laboratory worker was found infected with Cow Pox from an exposure while working in an unsafe biotech laboratory in the United States.  The worker was not working direclty with the virus but became infected because of a lack of biocontainment and decontamination issues.  The laboratory worker became infected in July 2010.  "The investigation revealed cowpox virus stocks in the laboratory's freezer but no known or intentional use of cowpox in the patient's laboratory in the previous 5 years,"  However, environmental swabbing indicated that virus was found on several surfaces in the laboratory and freezer room. Cowpox infections are transmissible.

http://promedmail.oracle.com/pls/otn/pm?an=20110209.0444

Friday, October 22, 2010

History of "Right to Know And What That Means Today for Biotech Workers" by Dan Berman

Daniel Berman On Pfizer Molecular Biologist Becky McClain Case


Daniel Berman, author of "Death On The Job" talked about the case of injured Pfizer
molecular biologist Becky McClain on April 27, 2010 in Sacramento. McClain was
doing stem cell research and was contaminated as a result of the lack of proper
health and safety protection at the Groton CT. Pfizer laboratories.

Tuesday, October 5, 2010

BL3 Lab Safety

A good article recently published by Gene Watch Magazine provides a insiders perspective of BL3 laboratory safety.  Here is the link:

A VIEW FROM THE INSIDE

By Nancy Connell
http://www.councilforresponsiblegenetics.org/GeneWatch/GeneWatchPage.aspx?pageId=287



Biolevel Safety 3 labs are under some regulatory control.  BL2 laboratories are not.  One could estimate that there could be at least 10,000 BL2 labs in the US,   Therefore, although BL3 labs work with dangerous select agents, BL2 labs pose more threat to the public since they are unregulated and unregistered and can cause human disease.

Saturday, September 11, 2010

Worker Safety in Biological Laboratories Is Lacking

The Council for Responsible Genetics has provided a superb overview of the harzards and lack of regulations covering the biotech industry.  See thier summary statment and link below for the full report.

Why would Pfizer, the world’s largest drug company, so mistreat and silence one of their top molecular biologists that a federal jury in Connecticut recently awarded her $1.37 million in damages? The answer promises to tear open the curtain covering hazards confronting tens of thousands of scientists and assistants in corporate, government and university labs. Becky McClain’s lawsuit against Pfizer claimed that the company’s sloppiness exposed her to an engineered form of the lentivirus, a virus related to one that could lead to immune deficiencies. It documented the absence of any available risk assessments and exposed the cruel refusal to give afflicted employees their own exposure records on the grounds that they are company trade secrets. Pfizer denied connections between its lab practices and Ms. McClain’s reoccurring paralysis and other illnesses. Becky McClain is not alone. As a revolution in genetic and other biological sciences has greatly expanded the number of laboratories in the past twenty years, workers in the biological industries have suffered from health and safety regulations that have fallen well behind the times. David Michaels, the head of OSHA, has admitted that there are “many gaps” in his agency’s standards. “New biological materials, nanomaterials, there are many things where we don’t have adequate information” (NY Times interview).


The Council for Responsible Genetics is mobilizing an effort to ensure that worker health and safety are once again protected in the United States by identifying hazards, educating the public and policy makers and working towards the creation of enforceable and openly accessible standards and practices for biological laboratories. Our new report represents an important step in this process as it lays out the current regulatory framework for commercial and academic biotechnology laboratories in the United States, identifies specific gaps in these regulations and offers some initial recommendations for improvements.

The full report can be accessed on the CRG website.

http://www.councilforresponsiblegenetics.org/pageDocuments/J118SCXSUR.pdf

Wednesday, August 18, 2010

Becky McClain Speaks on Biotechnology and Public Health and Safety



On July 17, 2010 in San Francisco, Pfizer injured biotech molecular biologist Becky McClain discussed her firing for making OSHA complaints and also the potential and real dangers of unregulated development of products in the biotech and nanotech industry without proper oversight. The first US conference on biotechnology and health and safety was sponsored by the California Coalition For Workers Memorial Day www.workersmemorialday.org Additional presentations at the conference are Biotech, CA Osha & Health And Safety Presentation With Dr. Larry Rose http://blip.tv/file/3916683 The Toxic Environment, Public Health, ACOEM And Pfizer:Presentation By Dr. Jack Thrasher http://blip.tv/file/3921769 Conflict of Interest By Judge Says Sandi Trend, Mother of Injured Agraquest Biotech Worker Bell http://blip.tv/file/3924484 Dina Padilla Speaks At Biotech & Health And Safety Conference http://www.youtube.com/watch?v=c_-_XEnaiNg It was also endorsed by Council For Responsible Genetics www.councilforresponsiblegenetics.org For additional information go to http://www.cpab.info/

http://www.blip.tv/file/3960030

Tuesday, July 27, 2010

Problems in Public Health and Safety and OSHA_Dr. Larry Rose


Dr. Larry Rose, M.D. a former OSHA physician spoke at the Conference on Biotechnology, Health and Safety, Labor and the Public held in San Francisco recently. Dr. Rose talked about the problems he incurred working at OSHA and the problems that exist today. He gave a good overview of how OSHA has become dysfunctional: Understaffing 1 to 90,000 workers, lack of expertise, diminished strength of unions and repressive political appointees who are pro corporate are all major factors in OSHA’s demise.

Dr. Rose also speaks on the secrecy of biological exposures and lack of public transparency, thereby making biotech appear safe, when in fact, it is dangerous work for the worker and the public.

Dr. Rose believes we have some good standards for protections of workers, but unfortunately, OSHA does not enforce the standards, leaving workers and the public at risk.

See Dr. Larry Rose's talk at the Conference on Biotechnology, Health and Safety, Labor and the Public held in San Francisco on July 17, 1010 at: http://www.blip.tv/file/3916683

Biofuels and Biosafety

NYTimes article:
Exploring Algae as Fuel
By ANDREW POLLACK
July 26, 1010
SAN DIEGO — In a laboratory where almost all the test tubes look green, the tools of modern biotechnology are being applied to lowly pond scum.
Foreign genes are being spliced into algae and native genes are being tweaked.
Different strains of algae are pitted against one another in survival-of-the-fittest contests in an effort to accelerate the evolution of fast-growing, hardy strains.
The goal is nothing less than to create superalgae, highly efficient at converting sunlight and carbon dioxide into lipids and oils that can be sent to a refinery and made into diesel or jet fuel.
“We’ve probably engineered over 4,000 strains,” said Mike Mendez, a co-founder and vice president for technology at Sapphire Energy, the owner of the laboratory. “My whole goal here at Sapphire is to domesticate algae, to make it a crop.”
Dozens of companies, as well as many academic laboratories, are pursuing the same goal — to produce algae as a source of, literally, green energy. And many of them are using genetic engineering or other biological techniques, like chemically induced mutations, to improve how algae functions.
“There are probably well over 100 academic efforts to use genetic engineering to optimize biofuel production from algae,” said Matthew C. Posewitz, an assistant professor of chemistry at the Colorado School of Mines, who has written a review of the field. “There’s just intense interest globally.”
Algae are attracting attention because the strains can potentially produce 10 or more times more fuel per acre than the corn used to make ethanol or the soybeans used to make biodiesel. Moreover, algae might be grown on arid land and brackish water, so that fuel production would not compete with food production. And algae are voracious consumers of carbon dioxide, potentially helping to keep some of this greenhouse gas from contributing to global warming.
But efforts to genetically engineer algae, which usually means to splice in genes from other organisms, worry some experts because algae play a vital role in the environment. The single-celled photosynthetic organisms produce much of the oxygen on earth and are the base of the marine food chain.
“We are not saying don’t do this,” said Gerald H. Groenewold, director of the University of North Dakota’s Energy and Environmental Research Center, who is trying to organize a study of the risks. “We say do this with the knowledge of the implications and how to safeguard what you are doing.”
At a meeting this month of President Obama’s new bioethics commission, Allison A. Snow, an ecologist at Ohio State University, testified that a “worst-case hypothetical scenario” would be that algae engineered to be extremely hardy might escape into the environment, displace other species and cause algal overgrowths that deprive waters of oxygen, killing fish.
A week earlier, at an industry-sponsored bioenergy conference, David Haberman, an engineer who has worked on an algae project, gave a talk warning of risks. Many scientists, particularly those in the algae business, say the fears are overblown. Just as food crops cannot thrive without a farmer to nourish them and fend off pests, algae modified to be energy crops would be uncompetitive against wild algae if they were to escape, and even inside their own ponds.
“Everything we do to engineer an organism makes it weaker,” said Stephen Mayfield, a professor of biology at the University of California, San Diego, and a co-founder of Sapphire. “This idea that we can make Frankenfood or Frankenalgae is just absurd.”
Dr. Mayfield and other scientists say there have been no known environmental problems in the 35 years that scientists have been genetically engineering bacteria, although some organisms have undoubtedly escaped from laboratories.
Even Margaret Mellon of the Union of Concerned Scientists, who has been critical of biotech crops, said that if genetically engineered algae were to escape, “I would not lose sleep over it at all.”
Still, some algae researchers worry they will be engulfed by the same backlash aimed at biotech foods and say care must be exercised. “About 40 percent of the oxygen that you and I are breathing right now comes from the algae in the oceans,” the genetic scientist J. Craig Venter said at a Congressional hearing in May. “We don’t want to mess up that process.”
Dr. Venter’s company, Synthetic Genomics, is getting $300 million from Exxon Mobil to create fuel-producing algae, in part by using synthetic genes. When the two companies cut the ribbon on a new greenhouse here earlier this month, Dr. Venter assured local dignitaries in attendance that no algae would escape. “Nothing will go into the drains, Mr. Mayor,” Dr. Venter said, only half-jokingly. “San Diego is safe.”
In the long run, Dr. Venter said, the algae should be given “suicide genes” that would kill them if they escaped the lab or fuel production facility. Some companies are sticking with searching for and breeding natural strains. “Re-engineering algae seems driven more by patent law and investor desire for protection than any real requirement,” said Stan Barnes, chief executive of Bioalgene, which is one of those companies. But Dr. Venter and Mr. Mendez argue that there are huge obstacles to making algae competitive as an energy source and that every tool will be needed to optimize the strains.
Sapphire Energy seems one of the best-positioned companies to do that. The company, which is three years old, has raised $100 million from prominent investors, including Bill Gates. Sapphire is also getting $100 million in federal financing to build a demonstration project containing 300 acres of open ponds in the New Mexico desert.
The company has inserted a gene into algae that allows the organisms to make a hydrocarbon they would not naturally produce, one that would help make fuel. “You don’t want to take what algae gives you,” said Mr. Mendez, who previously worked for medical biotechnology companies. “You want to make the best product.”
The company is also developing algae that can thrive in extremely salty and exceedingly alkaline water.
It has even developed what might be called Roundup Ready algae. Like the widely grown Roundup Ready soybeans, these algae are resistant to the herbicide Roundup. That would allow the herbicide to be sprayed on a pond to kill invading wild algae while leaving the fuel-producing strain unhurt.
Not all these traits are being developed by genetic engineering, because in many cases scientists do not know what genes to use. Instead, the company screens thousands of strains each day, looking for organisms with the right properties. Those desirable traits can be further enhanced by breeding or accelerated evolution.
In one room at Sapphire’s lab, parallel tubes contain algae with identical traits growing under identical conditions. But each strain is slightly different, and only the fastest growing one — determined by which tube turns the darkest green — will be chosen for further development.
“If you can’t outcompete your wild cousin, it doesn’t make it out of this room,” said Mr. Mendez. Algae can reproduce rapidly, doubling in as little as a few hours. And they can be carried long distances by the wind. “They have the potential to blow all over the world,” said Richard Sayre of the Donald Danforth Plant Science Center in St. Louis.
Dr. Sayre, who is also chief technology officer of Phycal, an algae company, is using genetic engineering to develop algae that capture less light. Right now, he explained, algae capture more light than they need and waste a lot of it as heat. If each organism captured less, then a given amount of light could be shared by more organisms, increasing biomass production.
Instead of using open ponds, some companies are using bioreactors, which typically contain the algae in tubes. Some experts say, however, that these would not totally prevent escapes. “The idea that you can contain these things and have a large-scale system is not credible,” said John R. Benemann, an industry consultant in Walnut Creek, Calif. He said, however, that he saw absolutely no risk from genetically engineered algae.
Sapphire says it is not growing any genetically engineered algae in open ponds yet. When it is ready, it says, it will comply with all regulations.
Genetically engineered algae, whether in open ponds or enclosed bioreactors, are likely to be regulated by the Environmental Protection Agency, which now regulates genetically engineered microbes under the Toxic Substances Control Act.
Still, there has been at least one case in which genetically modified algae seem to have fallen between the regulatory cracks. When Mera Pharmaceuticals, which is based in Hawaii, wanted to test the feasibility of producing human pharmaceuticals in genetically engineered algae in 2005, none of the three federal agencies that regulate the various areas of biotechnology — E.P.A., the Food and Drug Administration and the Agriculture Department — claimed jurisdiction.
Steven G. Chalk, acting deputy assistant secretary for renewable energy at the Energy Department, said any federally financed project, like Sapphire’s New Mexico demonstration, would have to undergo an environmental assessment. But risks would be assessed case by case, he said, not for all conceivable genetically modified algae.


http://www.nytimes.com/2010/07/26/business/energy-environment/26algae.html?_r=1&scp=2&sq=not just pond scum&st=cse

Wednesday, May 19, 2010

ANOTHER LABORATORY BIOSAFETY CASE_BIOTECH WORKER SICKENED WITH DANGEROUS INFECTIOUS AGENT

In light of all the recent biosafety issues, another biotech worker has become infected by an infectious microorganism while working in an infectious disease laboratory at University of Wisconsin-Madison. The University has been fined and a Professor of Infectious Disease has been punished by removal of his laboratory privileges.

University of W-Madison Professor Gary Splitter worked on Brucella, a microorganism which can cause Brucellosis, a major zoonotic disease. The disease can infect animals and can also cause a contagious disease in humans. Brucella is considered a bioterrorist agent. A biotech worker had become infected while working in Splitter's laboratory.

The Wisconsin State Journal states: "His lab created antibiotic-resistant strains of brucellosis and inserted them into mice in 2007 and possibly earlier, university officials said, without approval from local or federal agencies. The concern is that if someone contracted the antibiotic-resistant version of the disease created in the lab, treatment might have been more difficult." "

Splitter will lose his laboratory privileges for five years due to this serious biosafety incident and since his laboratory was not within recombinant DNA NIH standards. The university was fined $40,000 for their role also in violations of laboratory and public health and safety standards.

Biosafety is a current worker safety and public health and safety issue. Injured biotech workers can remain ill and untreated in the United States since diseases from genetically modified organisms or laboratory strains are difficult to diagnose. In addition biotech workers have no legal rights to appropriate exposure records for treatment after incurring an exposure.

Although academic labs such as University of Wisconsin are mandated to follow NIH guidelines, private industry is under no such constraint, leaving a big gap in public health and safety standards.

The biotech worker in Splitter's lab who became infected with Brucella remains unidentified.


links:
http://qwstnevrythg.com/2010/05/university-professor-barred/
http://www.huffingtonpost.com/2010/05/12/gary-splitter-u-of-wiscon_n_573391.html
http://cmr.asm.org/cgi/content/short/16/1/65
http://host.madison.com/wsj/news/local/education/university/article_bc095ae8-5d4a-11df-8e83-001cc4c03286.html
http://en.wikipedia.org/wiki/Brucellosis

http://www.antifascistencyclopedia.com/allposts/uw-madison-suspends-scientists-research-due-to-unauthorized-dangerous-bioterror-experimentsthe-lie

Tuesday, May 4, 2010

Geneticist Dies from Work-related Plague


University of Chicago geneticist may have died of an infection linked to the plague
09/21/2009
Erin Podolak

Malcolm Casadaban was researching the genetics of harmful bacteria, including a weakened strain of the bacteria that causes the plague, when he became infected.
On Sept. 13, University of Chicago geneticist Malcolm Casadaban died from an infection which has been attributed to a weakened laboratory strain of Yersinia pestis, the bacteria that causes the plague. Sixty- year-old Casadaban was working with Y. pestis, and other unspecified bacteria, for a genetic study.
According to a statement from the University of Chicago Medical Center, the laboratory strain of Y. pestis was found in blood samples taken from Casadaban after he was admitted to the Medical Center’s Bernard Mitchell Hospital. The finding suggests the possibility that Casadaban died from a form of infection known as septicemic plague, which can lead to death before any other physical symptoms of the disease develop.
Kenneth Alexander, chief of pediatric infectious disease at the medical center, described the case as a mystery. In a statement from the medical center, Alexander said that the bacterium is not typically fatal. The laboratory strain is engineered to lack the key proteins that cause it to be harmful to humans. The strain is considered so safe that it has even been used in some countries as a live-attenuated vaccine against the disease. The strain is approved by the Centers for Disease Control and Prevention (CDC) for routine laboratory use.
The infection control team at the medical center is working with the Chicago Department of Public Health (CDPH), the Illinois Department of Public Health, and the CDC to investigate Casadaban’s death. According to the Medical Center, no other illnesses related to the case have been reported.
Officials are looking into the possibility that an underlying medical condition may have contributed to Casadaban’s death. However, the medical center has reported that the initial autopsy indicated no obvious cause of death except for the presence of the bacteria in blood cultures. According to the medical center, conditions like high levels of iron in the blood can increase susceptibility to infection.
Though the strain is not known to be deadly, officials are taking all precautions. Casadaban’s lab has been sealed off in accordance with the investigation, and on Sept. 18, the medical center began notifying family, friends, colleagues, and health care personnel who had contact with Casadaban prior to his death. "While the death of this individual researcher is terrible and tragic, there is currently no indication that his case of illness spread to anyone else," the CDPH said in a statement.
Symptoms of the plague usually develop within 2-10 days of exposure. The University has reported that none of those who had contact with Casadaban have reported any illness. The typical treatment for the disease is a course of antibiotics.
Casadaban held degrees from Harvard, Stanford, and the Massachusetts Institute of Technology. He was also a member of the University of Chicago’s Institutional Biosafety Committee, which regulates research protocols for the use of biohazardous substances.
A memorial for Casadaban was held at the University on Sept. 16. A funeral service is planned for November. “This death is a tragic loss to our community,” James L. Madara, dean of the Biological Sciences Division and Pritzker School of Medicine, and CEO of the Medical Center, said in a statement. “We are all saddened to lose a valued colleague.” Those wishing to make donations have been asked to contribute to the American Diabetes Research Association.
The plague appears in three forms, septicemic, pneumonic, and bubonic. The bubonic plague infects the lymph nodes and is infamous for the outbreak in Europe in the 1300s. Pneumonic plague infects the lungs. Septicemic plague is an infection of the blood. It is the rarest of the three forms, but considered the most lethal.
Infection due to the modified strain of Y. pestis is so rare that data regarding infection rate is unavailable. In the United States about 20 cases of plague are reported each year due to unmodified strains of Y. pestis. Plague remains a significant problem in developing countries where up to 3,000 cases are reported yearly.

Thursday, April 22, 2010

Laboratory Safety at RISK



by Rita Uplend on April 20, 2010


Army investigators have recommended laboratory safety procedures at Fort Detrick be reviewed after finding lapses following the infection of a biodefense worker with tularemia.
The infected woman survived the tularemia infection, which is a potentially fatal respiratory disease, following a brief hospitalization at Walter Reed Army Medical Center in December.The U.S. Army Medical Research Institute of Infectious Diseases, in an executive summary of an internal investigation, said that the unidentified woman probably inhaled the tularemia bacteria between November 13 and November 17.Investigators could not pinpoint one significant event, such as a spill or dropped flask, but noted several lapses in proper laboratory techniques that, when combined, may have increased the woman's risk of exposure.Among the lapses cited in the report was potentially contaminated waste that wasn't placed in a cabinet designed to contain bacteria. The waste was instead deposited in a waste container inside the sealed laboratory suite.The woman, who had not taken part in a voluntary immunization with an experimental tularemia vaccine, wasn't wearing a battery-powered device that delivers filtered air into a plastic hood, which is required.
The woman instead wore a half-face filter respirator, which had been deemed sufficient as blood tests showed the woman had developed antibodies to tularemia.The worker also was not clear on proper procedures for illness reporting and did not immediately report her symptoms. When her symptoms were finally reported, the woman did not immediately notify the institute's Special Immunization Clinic for an evaluation to determine if her illness was work-related.Among the report's recommendations are a call for a review of standard lab procedures for working with tularemia, a re-evaluation of vaccination policies and the use of personal protective gear for tularemia, and the formulation of an official policy for reporting illnesses and monitoring employee absences.

Friday, April 9, 2010

Safety Lapses with Infected Biotech Worker at Defense Lab


Apr 6, 2010 6:26 pm US/Eastern
Army Finds Safety Lapses In Lab Infection Case


DAVID DISHNEAU, Associated Press Writer

HAGERSTOWN, Md. (AP) ― Army investigators at Fort Detrick recommended on Tueday that some laboratory safety procedures be reviewed after finding lapses in the case of a biodefense worker who became infected with tularemia, a potentially fatal respiratory disease.The woman survived the infection after a brief hospitalization at Walter Reed Army Medical Center in December.In an executive summary of an internal investigation, the U.S. Army Medical Research Institute of Infectious Diseases said the unidentified woman probably inhaled the bacteria between Nov. 13 and Nov. 17.Although there was no significant event investigators could point to, such as a spill or dropped flask, they cited several lapses in proper laboratory techniques that, taken together, may have increased her risk of exposure.The report said potentially contaminated waste wasn't placed in a cabinet designed to contain bacteria. Instead, it was deposited in a waste container inside the sealed laboratory suite.Even though she hadn't been voluntarily immunized with an experimental tularemia vaccine, the woman wasn't wearing a battery-powered device that delivers filtered air into a plastic hood, as required. Instead, she wore a half-face filter respirator. The less-protective device apparently was deemed sufficient because a blood test indicated she had developed antibodies to tularemia, perhaps due to a natural exposure in the past.The worker wasn't clear on the proper procedures for illness reporting, investigators found. She didn't immediately report her symptoms and when she did, on Nov. 23, she failed to immediately notify a second office, the institute's Special Immunizations Clinic, for an evaluation to determine if the illness could be work-related. She finally reported to the clinic on Dec. 1.The report's recommendations include a review of standard laboratory procedures for working with tularemia; a re-evaluation of policies for vaccination and the use of personal protective gear for tularemia; and formulation of an official policy for reporting illnesses and monitoring employee absences.
(© 2010 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.)

Thursday, April 8, 2010

Dangerous Biological Testing Lab in Connecticut


New Public Health Laboratory Approved By Bond Commission; Union Dispute Over Who Will Build It
By Christopher Keating on April 7, 2010 12:34 PM
http://blogs.courant.com/capitol_watch/2010/04/new-public-health-laboratory-a.html
In a continuing political battle, the State Bond Commission approved a new, $70 million public health laboratory that has drawn sharp opposition from the surrounding Rocky Hill neighbors.
The 7 to 3 vote Wednesday came after a similar vote last month had failed on a 5 - 5 tie as all five Democrats on the commission banded together after saying that the neighbors had not had enough time to analyze the plans.
The state-of-the-art facility would allow for testing for anthrax and other biohazardous materials, which has raised fears among the neighbors. The lab will be a replacement for the deteriorating, 45-year-old lab in Hartford, which is within walking distance of the state Capitol, the Bushnell theatre, the state office building on Capitol Avenue, and Bushnell Park. Thousands of people walk and work near the currrent laboratory on a daily basis, and many are not aware of its location in a non-descript building near the state DEP headquarters.
Republican Gov. M. Jodi Rell said previously that many of the concerns about the facility were actually related to a union battle over whether non-union contractors would be building the $70 million complex. One of the chief opponents of the laboratory is Shaun Cashman, a high-ranking union official who once served as the state labor commissioner under then-Gov. John G. Rowland.
State officials were surprised when Cashman recently showed up at a private meeting about the laboratory plans with two Democrats - Sen. Paul Doyle of Wethersfield and Rep. Tony Guerrera of Rocky Hill. Cashman attended the bond commission meeting Wednesday and often looked back at Doyle and Guerrera, who were standing in the back of the room.
When asked after the vote whether the dispute is over union issues, Cashman said, "I'm just looking for safety. I have no other issue beyond that.''
He then walked away from a reporter.
More than 30 different contractors are recommended to work on the project, including about a dozen with contracts for at least $1 million. Some of the biggest contractors on the list are Tucker Mechanical, Pioneer Valley Concrete, United Steel, S. G. Milazzo & Co., Ductco Inc., Gibson Associates, Electrical Contractors Inc., and Simscroft-Echo Farms, Inc. of Simsbury. Other contractors are Century Drywall Inc., WDJ Construction, CT Mason Contractors Inc., Gold Seal Roofing & Sheetmetal Inc., and Suntech of CT, Inc.
The three Democrats who voted against the laboratory were Attorney General Richard Blumenthal, state Comptroller Nancy Wyman and state Rep. David McCluskey of West Hartford. Sen. Eileen Daily, a moderate Democrat and key swing voter on the bond commission, changed her vote from last month and supported the laboratory on Wednesday. She told Capitol Watch that her concerns had been answered.
After the original vote last month, Rell told reporters that she was angry and frustrated by the process. She said the plans had been in the works for five years and were well known to town officials in Rocky Hill.
Rell's aides distributed a timeline and lengthy details about the plan to show that Rocky Hill officials had been aware of the proposal for years.
The lab is a critical component of the state's public health mission. Scientists at the current lab test for West Nile virus, childhood lead poisoning, rabies, and drinking water contamination, among other public health concerns.
The issue over the Rocky Hill location flared up when a group known as Construction Workers For A Safe Environment started distributing fliers to Rocky Hill residents with the statement that the materials at the new lab "may cause serious or potentially lethal disease as a result of exposure by the inhalation route."
Stanley Einhorn, a Rocky Hill resident who found a flier on his doorstep last week, said last month that everyone on his street got the flier, which says the Rocky Hill laboratory would be at the same level as the notorious laboratory at Plum Island, N.Y., in Long Island Sound. But Rocky Hill's, like the lab it would replace, would be a Level 3 laboratory, while Plum Island is a Level 4 facility.
"It's not as bad as Plum Island, but there are contagious things there," Einhorn said. "I definitely think it's a bad idea. ... There's a lot of potential problems."
Doyle, the state senator who sought a postponement of the bond commission vote, said last month that the brochure was "inflammatory" and "dead wrong" in certain aspects regarding the state's plans.
"This facility has no live animals. It's not like they're testing live animals like at Plum Island," Doyle said. "There's a lot of misstatements in here. You can't get near Plum Island. There's 100 percent security."
Doyle rejected the notion that the dispute was about union construction jobs, saying that the issue never came up during the one-hour meeting with public health commissioner Robert Galvin and other state health department officials at the state Capitol complex.
"I don't know any of those [union] issues because Cashman didn't tell me any of that," Doyle said last month. "The motives of Cashman are irrelevant. ... In the meeting, there was nothing about unions. It was all science."
The new laboratory, which is scheduled to be built on 22 acres near the State Veterans Home and across the street from Dinosaur State Park, would replace the current lab at 10 Clinton St. in a densely packed, congested area of downtown Hartford.
Because of the weak economy and the heavy competition among contractors for construction jobs, the state had received a bid that was $12 million less than expected.
Galvin, the public health commissioner, has described the current lab in Hartford as antiquated and said its plumbing, heating and air-conditioning systems are deficient. On hot days in the summer, staff members must put containers of ice on top of specimen coolers to ensure that the samples are kept cold enough, he said.
Galvin told the bond commission last month that the lab has no experimental animals and that it's never had trouble containing organisms it is testing.
A construction contractor has offered a price that would cut $12 million off the overall cost, and that offer expires April 15, Galvin said.